SCHEMBL22493465

SCHEMBL22493465

CC(C)(C)NCCc1cccnc1-c1cccc(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 9/20 0.40
KCNN4 O15554 4/20 0.40
KCNH2 Q12809 2/20 0.39
CDC7 O00311 1/20 0.39
ROCK2 O75116 1/20 0.39
MAP4K4 O95819 1/20 0.39
PIM1 P11309 1/20 0.39
PRKACA P17612 1/20 0.39
CDK2 P24941 1/20 0.39
GSK3B P49841 1/20 0.39
HIPK2 Q9H2X6 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
IRAK4 Q9NWZ3 1/20 0.39
TDO2 P48775 1/20 0.36
TRPA1 O75762 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
SYK P43405 1/20 0.35
TRPV1 Q8NER1 2/20 0.35
KDM4E B2RXH2 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22493347 0.84 KCNN4 (0.44) KCNA5KCNN4TRPV1KDM4E
SCHEMBL3911088 0.78 TAAR1 (0.50) KCNA5KCNN4KCNH2CDC7ROCK2
SCHEMBL3908011 0.76 KMT2A (0.42) KCNA5KCNN4ADORA2AADORA1CYP1A2
SCHEMBL22481177 0.74 ADRB2 (0.48) KCNA5CDC7ROCK2MAP4K4PIM1
SCHEMBL22864224 0.72 SLC40A1 (0.39) KDM4E
SCHEMBL16132335 0.72 TDO2 (0.43) KCNA5KCNH2CDC7ROCK2MAP4K4
SCHEMBL3913880 0.71 KCNA5 (0.40) KCNA5KCNN4KCNH2CDC7ROCK2
SCHEMBL22493402 0.71 P2RX7 (0.37)
SCHEMBL22493472 0.71 TRPV3 (0.43) KCNH2MAP4K4KDM4E
SCHEMBL22493867 0.71 CD38 (0.38) KCNH2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024137506-A1 COMPOSITIONS AND METHODS FOR IMPROVING NEUROLOGICAL DISEASES AND DISORDERS CURASEN THERAPEUTICS, INC. (US) 2024-06-27 WO disclosed
WO-2023225021-A1 COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) CURASEN THERAPEUTICS, INC. (US) 2023-11-23 WO disclosed
WO-2020198466-A9 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed
WO-2020198466-A1 BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME CURASEN THERAPEUTICS, INC. (US) 2020-10-01 WO disclosed